Your browser doesn't support javascript.
loading
Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli.
Houamel, Dounia; Ducrot, Nicolas; Lefebvre, Thibaud; Daher, Raed; Moulouel, Boualem; Sari, Marie-Agnes; Letteron, Philippe; Lyoumi, Said; Millot, Sarah; Tourret, Jerome; Bouvet, Odile; Vaulont, Sophie; Vandewalle, Alain; Denamur, Erick; Puy, Hervé; Beaumont, Carole; Gouya, Laurent; Karim, Zoubida.
Afiliação
  • Houamel D; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France;
  • Ducrot N; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France;
  • Lefebvre T; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France; AP-HP, French Center for Porphyrias, Louis Mourier Hospital, Colombes, Franc
  • Daher R; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France;
  • Moulouel B; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France;
  • Sari MA; The National Centre for Scientific Research (CNRS), UMR 8601, Descartes University, Paris, France;
  • Letteron P; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France;
  • Lyoumi S; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France;
  • Millot S; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France;
  • Tourret J; Paris Diderot University, Sorbonne Paris Cité, Paris, France; INSERM U1137, Infection Antimicrobials Modelling Evolution (IAME) Laboratory, Paris, France; and.
  • Bouvet O; Paris Diderot University, Sorbonne Paris Cité, Paris, France; INSERM U1137, Infection Antimicrobials Modelling Evolution (IAME) Laboratory, Paris, France; and.
  • Vaulont S; Laboratory of Excellence, GR-Ex, Paris, France; INSERM U1016, Cochin Institute, Descartes University, Paris, France.
  • Vandewalle A; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France;
  • Denamur E; Paris Diderot University, Sorbonne Paris Cité, Paris, France; INSERM U1137, Infection Antimicrobials Modelling Evolution (IAME) Laboratory, Paris, France; and.
  • Puy H; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France; AP-HP, French Center for Porphyrias, Louis Mourier Hospital, Colombes, Franc
  • Beaumont C; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France;
  • Gouya L; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France; AP-HP, French Center for Porphyrias, Louis Mourier Hospital, Colombes, Franc
  • Karim Z; National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France; zoubida.karim@inserm.fr.
J Am Soc Nephrol ; 27(3): 835-46, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26293821
The iron-regulatory peptide hepcidin exhibits antimicrobial activity. Having previously shown hepcidin expression in the kidney, we addressed its role in urinary tract infection (UTI), which remains largely unknown. Experimental UTI was induced in wild-type (WT) and hepcidin-knockout (Hepc-/-) mice using the uropathogenic Escherichia coli CFT073 strain. Compared with infected WT mice, infected Hepc-/- mice showed a dramatic increase in renal bacterial load. Moreover, bacterial invasion was significantly dampened by the pretreatment of WT mice with hepcidin. Infected Hepc-/- mice exhibited decreased iron accumulation in the renal medulla and significant attenuation of the renal inflammatory response. Notably, we demonstrated in vitro bacteriostatic activity of hepcidin against CFT073. Furthermore, CFT073 repressed renal hepcidin, both in vivo and in cultured renal cells, and reduced phosphorylation of SMAD kinase in vivo, suggesting a bacterial strategy to escape the antimicrobial activities of hepcidin. In conclusion, we provide new mechanisms by which hepcidin contributes to renal host defense and suggest that targeting hepcidin offers a strategy to prevent bacterial invasion.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Urinárias / Escherichia coli / Infecções por Escherichia coli / Hepcidinas / Anti-Infecciosos Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Urinárias / Escherichia coli / Infecções por Escherichia coli / Hepcidinas / Anti-Infecciosos Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article